Strategic Account Executive (Pacific Northwest)

The role

The Strategic Account Executive will drive programmatic adoption of Freenome's early cancer detection tests and digital health platform. This role involves building relationships with health systems and negotiating contracts to meet sales goals.

What you will do

• Become a subject matter expert in Freenome's technology and service offerings
• Articulate the value of tests and digital health tools to executive and provider leadership
• Partner with Medical Affairs to educate and recruit Health Systems
• Negotiate and close contracts with health systems and institutions
• Collaborate with stakeholders to implement EMR and UX tools
• Capture customer interaction information using CRM tools
• Provide customer feedback to the Product and Marketing team
• Structure strategic plans for gaining and retaining contracts
• Identify market opportunities and monitor competitive activity

Required qualifications

• Bachelor's Degree in Sales, Business Management, Marketing, Science, or any other related field
• 10+ years of medical sales experience
• 3+ years of success selling complex diagnostics solutions to health systems or institutions
• Experience with institutional sales successfully closing and implementing contracts with health systems
• Understanding of the healthcare system, reimbursement pathways, and screening protocols
• Strong communication, negotiation, and stakeholder engagement skills
• Strong presentation skills
• Experience with CRM tools and data-driven account planning
• Ability to sell technically complex products
• Possession of a valid driver's license

Nice to have

• Experience with liquid biopsy early cancer detection
• Demonstrated experience promoting digital health solutions to health systems
• Experience selling disruptive technologies and improving the standard of care

Benefits

• Equity
• Cash bonuses
• Medical benefits
• Financial benefits
• Other benefits

About the company

Freenome is seeking a Strategic Account Executive to help redefine the landscape of early cancer detection by driving programmatic adoption of screening in health systems.